CD47 and heart disorder: Recently, multiple studies reported that CD47 is abnormally expressed in various heart diseases (Heidt et al., 2014; Chen et al., 2019; Engelbertsen et al., 2019), resulting in damage to the cardiomyocyte surface, impaired macrophage phagocytotic activity, and reduced clearance of dead cells in the infarct area.